Guide
QC release cycle time and biotech scale-up
Manufacturing can look healthy while release is already the constraint. Deviation rate and method load rise with scale; without matching QC capacity and maturity, heat builds toward audit and timeline failure.
Symptoms
- Lots complete on the floor but sit weeks awaiting disposition
- Method transfer and stability work crowding routine release
- Deviation backlog growing faster than closures
- Leadership tracking bioreactor KPIs while ignoring queue time
What good looks like this quarter
A ranked view of release bottlenecks vs other scale risks, clear ownership, and a Now/Next/Later path that protects the next milestone without boiling the ocean.
Start with the Scale-Up Readiness scorecard or email BiOS to check fit for the fixed-fee assessment.